{"id":"topical-tetracycline","safety":{"commonSideEffects":[{"rate":null,"effect":"Local skin irritation or erythema"},{"rate":null,"effect":"Photosensitivity (rare with topical formulation)"},{"rate":null,"effect":"Allergic contact dermatitis"}]},"_chembl":{"chemblId":"CHEMBL454950","moleculeType":"Small molecule","molecularWeight":"480.90"},"_dailymed":{"setId":"0961b097-ba41-40c2-aaec-dd291841bf09","title":"TETRACYTE TOPICAL TETRACYCLINE HYDROCHLORIDE (TETRACYCLINE HYDROCHLORIDE) SPRAY [VIADERMA DISTRIBUTION INC]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Tetracycline is a broad-spectrum antibiotic that penetrates bacterial cells and binds reversibly to the 30S ribosomal subunit, blocking aminoacyl-tRNA from entering the A site and preventing peptide bond formation. When applied topically, it achieves high local concentrations at the site of infection or inflammation while minimizing systemic absorption. This mechanism makes it effective against a wide range of gram-positive and gram-negative bacteria commonly found in skin infections.","oneSentence":"Topical tetracycline inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, reducing microbial growth on the skin surface.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:38:51.990Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Bacterial skin infections (acne, impetigo, infected wounds)"},{"name":"Topical prophylaxis and treatment of superficial skin infections"}]},"trialDetails":[{"nctId":"NCT07343635","phase":"NA","title":"The Efficacy and Safety of Anti-inflammation Treatment (Hirudoid Introduction Followed by Yellow Light Therapy) Combined With Tofacitinib and Doxycycline in Chinese Adult Patients With Mild to Moderate Erythematous Telangiectatic Rosacea","status":"RECRUITING","sponsor":"The Fourth Affiliated Hospital of Zhejiang University School of Medicine","startDate":"2026-02-01","conditions":"Erythematotelangiectatic Rosacea","enrollment":186},{"nctId":"NCT01631617","phase":"PHASE2","title":"Effects of Treatments on Atopic Dermatitis","status":"RECRUITING","sponsor":"National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)","startDate":"2012-09-18","conditions":"Eczema, Dermatitis, Skin Diseases, Genetic","enrollment":130},{"nctId":"NCT06120140","phase":"PHASE2","title":"Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib","status":"RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2024-02-16","conditions":"Carcinoma, Non-Small-Cell Lung","enrollment":300},{"nctId":"NCT07462702","phase":"EARLY_PHASE1","title":"Topical Minocycline for CARP","status":"NOT_YET_RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2026-06-01","conditions":"Confluent and Reticulated Papillomatosis (CARP)","enrollment":35},{"nctId":"NCT04582383","phase":"PHASE4","title":"Comparative Effectiveness Study of Spironolactone Versus Doxycycline for Acne","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Pennsylvania","startDate":"2022-03-30","conditions":"Acne","enrollment":350},{"nctId":"NCT03489629","phase":"PHASE2","title":"STaph Aureus Resistance-Treat Early and Repeat (STAR-TER)","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2018-04-03","conditions":"Cystic Fibrosis","enrollment":37},{"nctId":"NCT04207931","phase":"PHASE4","title":"Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2018-04-30","conditions":"Central Centrifugal Cicatricial Alopecia (CCCA)","enrollment":250},{"nctId":"NCT04108897","phase":"EARLY_PHASE1","title":"Analysis of the Microbiome in Rosacea","status":"ACTIVE_NOT_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2019-09-17","conditions":"Rosacea","enrollment":150},{"nctId":"NCT03162497","phase":"PHASE4","title":"Effect of Topical Azithromycin on Tear Film Thickness in Patients With Meibomian Gland Dysfunction","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2018-01-08","conditions":"Dry Eye Syndromes, Meibomian Gland Dysfunction","enrollment":23},{"nctId":"NCT02837965","phase":"","title":"Observational Study Assessing Outcomes, Treatment Patterns and Related Costs in Patients in Bullous Pemphigoid","status":"COMPLETED","sponsor":"CHU de Reims","startDate":"2013-09-26","conditions":"Bullous Pemphigoid","enrollment":149},{"nctId":"NCT06252194","phase":"PHASE2","title":"Comparative Study of Metformin Versus Doxycycline in Moderate to Severe Adult Acne Vulgaris Patients.","status":"UNKNOWN","sponsor":"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh","startDate":"2023-03-05","conditions":"Acne Vulgaris","enrollment":120},{"nctId":"NCT04960930","phase":"PHASE3","title":"To Evaluate the Efficacy and Safety of Minocycline Hydrochloride Foam in the Treatment of Moderate-to-severe Acne Vulgaris","status":"COMPLETED","sponsor":"Cutia Therapeutics (Shanghai) Co., Ltd","startDate":"2021-09-17","conditions":"Acne Vulgaris","enrollment":372},{"nctId":"NCT03334682","phase":"PHASE3","title":"Randomized Double-blind Study on the Benefit of Spironolactone for Treating Acne of Adult Woman.","status":"COMPLETED","sponsor":"Nantes University Hospital","startDate":"2018-01-31","conditions":"Acne Vulgaris","enrollment":158},{"nctId":"NCT04940767","phase":"PHASE4","title":"A Companion Treatment Study for Patients With Moderate to Severe Acne Vulgaris","status":"COMPLETED","sponsor":"Edward Lain, MD","startDate":"2021-06-28","conditions":"Acne Vulgaris","enrollment":31},{"nctId":"NCT02899000","phase":"PHASE4","title":"A Treatment for Severe Inflammatory Acne Subjects","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2016-07-29","conditions":"Acne Vulgaris","enrollment":186},{"nctId":"NCT01874860","phase":"PHASE2","title":"Skin Rash Study Before Chemotherapy in Colorectal & Head and Neck Cancer Patients","status":"COMPLETED","sponsor":"University of Louisville","startDate":"2013-08","conditions":"Colorectal Cancer, Head and Neck Cancer","enrollment":24},{"nctId":"NCT00892281","phase":"PHASE4","title":"ORCA - Oracea® for Rosacea: A Community-based Assessment","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2009-04","conditions":"Rosacea","enrollment":1421},{"nctId":"NCT01426269","phase":"PHASE4","title":"Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® vs Placebo","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2011-09","conditions":"Rosacea","enrollment":235},{"nctId":"NCT02946788","phase":"PHASE2","title":"Open Label Photo-Documentation Study Of BPX-01 Minocycline Gel","status":"COMPLETED","sponsor":"BioPharmX, Inc.","startDate":"2017-03-13","conditions":"Acne Vulgaris","enrollment":20},{"nctId":"NCT03173053","phase":"NA","title":"S. Aureus Decolonization in HPN Patients.","status":"TERMINATED","sponsor":"Radboud University Medical Center","startDate":"2018-02-08","conditions":"Staphylococcus Aureus, Motility Disorder","enrollment":63},{"nctId":"NCT04721626","phase":"","title":"Topical Antisepsis in Head and Neck Cancer Surgery","status":"COMPLETED","sponsor":"Medical College of Wisconsin","startDate":"2021-01-06","conditions":"Head and Neck Cancer","enrollment":25},{"nctId":"NCT02815267","phase":"PHASE3","title":"A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne","status":"COMPLETED","sponsor":"Vyne Therapeutics Inc.","startDate":"2016-05","conditions":"Acne Vulgaris","enrollment":466},{"nctId":"NCT03271021","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 in the Treatment of Moderate-to-Severe Acne Vulgaris","status":"COMPLETED","sponsor":"Vyne Therapeutics Inc.","startDate":"2017-07-17","conditions":"Acne Vulgaris","enrollment":1488},{"nctId":"NCT02815280","phase":"PHASE3","title":"A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne","status":"COMPLETED","sponsor":"Vyne Therapeutics Inc.","startDate":"2016-05","conditions":"Acne Vulgaris","enrollment":495},{"nctId":"NCT04202263","phase":"PHASE2","title":"Assessment of Suppression of Cutaneous Allergic Responses and Pruritis by Topical Minocycline","status":"UNKNOWN","sponsor":"State University of New York - Downstate Medical Center","startDate":"2019-09-26","conditions":"Allergic Rhinitis, Asthma","enrollment":25},{"nctId":"NCT03075891","phase":"PHASE4","title":"Oracea Soolantra Association in Participants With Severe Rosacea","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2017-07-05","conditions":"Rosacea","enrollment":273},{"nctId":"NCT03888378","phase":"PHASE2","title":"Study to Evaluate the Safety and Efficacy of Minocycline Ointment in Subjects With Inflamed Meibomian Gland Dysfunction","status":"COMPLETED","sponsor":"Hovione Scientia Limited","startDate":"2019-04-02","conditions":"Meibomian Gland Dysfunction, MGD-Meibomian Gland Dysfunction","enrollment":270},{"nctId":"NCT00688064","phase":"PHASE3","title":"Adapalene-BPO Gel Associated With Doxycycline Hyclate 100 mg in the Treatment of Severe Acne Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2008-08","conditions":"Severe Acne Vulgaris","enrollment":459},{"nctId":"NCT01014689","phase":"PHASE3","title":"Comparison of Epiduo Associated With Lymecycline Versus Epiduo Vehicle Associated With Lymecycline in Acne Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2009-08","conditions":"Acne Vulgaris","enrollment":378},{"nctId":"NCT01474590","phase":"PHASE3","title":"Efficacy & Safety Comparison of Epiduo With Doxycycline Versus Vehicle With Isotretinoin in the Treatment of Severe Acne","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2011-11","conditions":"Acne","enrollment":266},{"nctId":"NCT00855595","phase":"PHASE4","title":"Efficacy of Topical Azelaic Acid 15% Gel Plus Anti-inflammatory Dose Doxycycline or Metronidazole Gel 1% Plus Anti-inflammatory Dose Doxycycline in Moderate Papulopustular Rosacea","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2009-02","conditions":"Papulopustular Rosacea","enrollment":207},{"nctId":"NCT03656484","phase":"PHASE2","title":"New Periodontitis Treatment Based on Hyaluronic Acid and Melatonin","status":"COMPLETED","sponsor":"Concordia Dent Srl","startDate":"2019-01-15","conditions":"Chronic Periodontitis","enrollment":50},{"nctId":"NCT01867294","phase":"PHASE2","title":"Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab","status":"COMPLETED","sponsor":"Academic and Community Cancer Research United","startDate":"2012-08-31","conditions":"Advanced Malignant Neoplasm, Dermatologic Complication","enrollment":19},{"nctId":"NCT03263273","phase":"PHASE2","title":"Study to Evaluate the Safety and Efficacy of Topical Minocycline Gel in Patients With Papulopustular Rosacea","status":"COMPLETED","sponsor":"Hovione Scientia Limited","startDate":"2017-10-30","conditions":"Rosacea, Papulopustular Rosacea","enrollment":270},{"nctId":"NCT04125706","phase":"NA","title":"Locally Delivered Antibiotics for the Treatment of Periodontitis","status":"UNKNOWN","sponsor":"Riyadh Elm University","startDate":"2019-11-01","conditions":"Periodontitis","enrollment":44},{"nctId":"NCT02735837","phase":"PHASE2, PHASE3","title":"The Effect of Topical Doxycycline Gel on HbA1c in Patients With Type 2 Diabetes Mellitus(DM) ®","status":"COMPLETED","sponsor":"Amirhossein Farahmand","startDate":"2015-01","conditions":"Diabetes Mellitus With Periodontal Disease","enrollment":24},{"nctId":"NCT03457636","phase":"PHASE4","title":"The Use of Oracea and Epiduo Forte in Severe Acne Patients","status":"COMPLETED","sponsor":"Derm Research, PLLC","startDate":"2018-03-19","conditions":"Acne","enrollment":22},{"nctId":"NCT01465802","phase":"PHASE2","title":"Study Of Dacomitinib (PF-00299804) In Advanced NSCLC Patients (Post Chemo Or Select First Line) To Evaluate Prophylactic Intervention On Derm And GI AEs And PRO","status":"COMPLETED","sponsor":"Pfizer","startDate":"2011-12-26","conditions":"Non Small Cell Lung Cancer (NSCLC)","enrollment":236},{"nctId":"NCT03634605","phase":"NA","title":"Effect of Tetracycline Pleurodesis on Prevention of Primary Spontaneous Pneumothorax Recurrence","status":"COMPLETED","sponsor":"Isfahan University of Medical Sciences","startDate":"2015-05-05","conditions":"Primary Spontaneous Pneumothorax","enrollment":50},{"nctId":"NCT03611920","phase":"","title":"Effect of Topical Tetracycline and Dexamethasone on Periodontal and Pulpal Regeneration of Replanted Avulsed Teeth","status":"COMPLETED","sponsor":"University of Bern","startDate":"2000-08-14","conditions":"Dental Trauma, Avulsion, Periodontal Regeneration","enrollment":33},{"nctId":"NCT02239731","phase":"PHASE2","title":"Safety, Tolerability and Efficacy Study of Doxycycline Foam for the Prevention of EGFRI Skin Toxicity in Cancer Patients","status":"COMPLETED","sponsor":"Vyne Therapeutics Inc.","startDate":"2014-10","conditions":"Rash Due to Epidermal Growth Factor Receptor Inhibitors","enrollment":24},{"nctId":"NCT00803452","phase":"PHASE4","title":"Lipids of the Human Tear Film and Their Effect on Tear Stability","status":"COMPLETED","sponsor":"University of Louisville","startDate":"2008-07","conditions":"Blepharitis","enrollment":31},{"nctId":"NCT03269214","phase":"NA","title":"Use of Topical Phenytoin in Bisphosphonate-related Osteonecrosis of the Mandible","status":"COMPLETED","sponsor":"Shiraz University of Medical Sciences","startDate":"2012-09-01","conditions":"Osteonecrosis Due to Drugs, Jaw","enrollment":20},{"nctId":"NCT00347776","phase":"PHASE4","title":"Study of Azithromycin to Prevent Recurrent Trichiasis Following Surgery in Ethiopia","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2001-08","conditions":"Trichiasis","enrollment":1452},{"nctId":"NCT01349192","phase":"PHASE2","title":"Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)","status":"TERMINATED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2011-04","conditions":"Cystic Fibrosis, Methicillin-resistant Staphylococcus Aureus","enrollment":47},{"nctId":"NCT00764361","phase":"PHASE2","title":"Safety Study of Topical Doxycycline Gel for Adult Diabetic Lower Extremity Ulcers","status":"COMPLETED","sponsor":"NanoSHIFT LLC","startDate":"2009-01","conditions":"Diabetic Foot Ulcer","enrollment":15},{"nctId":"NCT00473083","phase":"PHASE2","title":"Systemic and Topical Treatments for Rash Secondary to Erlotinib in Lung Cancer","status":"COMPLETED","sponsor":"British Columbia Cancer Agency","startDate":"2009-01","conditions":"Rash","enrollment":150},{"nctId":"NCT02538224","phase":"PHASE2, PHASE3","title":"Efficacy of Subgingivally Delivered Doxycycline Plus Ketoprofen Gel as an Adjunct to Non-surgical Periodontal Treatment","status":"COMPLETED","sponsor":"Islamic Azad University, Sanandaj","startDate":"2013-07","conditions":"Chronic Periodontitis","enrollment":20},{"nctId":"NCT02036528","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Gentamicin Topical Gel (AppliGel-G) for Treatment of Mild to Moderately Infected Diabetic Foot Ulcers","status":"TERMINATED","sponsor":"Royer Biomedical, Inc.","startDate":"2014-01","conditions":"Diabetic Foot Ulcers","enrollment":9},{"nctId":"NCT02142543","phase":"EARLY_PHASE1","title":"The Effect of 2-DeNT Oral Topical Powder on Minor Recurrent Aphthous Ulcer","status":"COMPLETED","sponsor":"Texas A&M University","startDate":"2012-03","conditions":"Minor Recurrent Aphthous Stomatitis Lesions","enrollment":23},{"nctId":"NCT00240513","phase":"PHASE4","title":"Study Comparing Acne in Patients Taking Oral Minocycline to Patients Taking Minocycline Plus Topical Tretinoin","status":"TERMINATED","sponsor":"Derm Research @ 888 Inc.","startDate":"2004-08","conditions":"Acne Vulgaris","enrollment":38},{"nctId":"NCT01206348","phase":"PHASE4","title":"Combination Treatment for Moderate to Severe Acne","status":"COMPLETED","sponsor":"Medicis Global Service Corporation","startDate":"2010-09","conditions":"Acne","enrollment":97},{"nctId":"NCT01245946","phase":"PHASE2","title":"Photodynamic Therapy Compared to Adapalene 0.1% Gel Plus Doxycycline in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Pontificia Universidad Catolica de Chile","startDate":"2010-10","conditions":"Acne","enrollment":46},{"nctId":"NCT01083420","phase":"PHASE3","title":"The Efficacy of Topical Minocycline in Managing Symptomatic Oral Lichen Planus","status":"UNKNOWN","sponsor":"Sheba Medical Center","startDate":"2010-03","conditions":"Oral Lichen Planus","enrollment":30},{"nctId":"NCT01049438","phase":"NA","title":"A Prospective Trial of Nasal Mupirocin, Hexachlorophene Body Wash, and Systemic Antibiotics for Prevention of Recurrent Methicillin Resistant Staphylococcus Aureus Infections","status":"COMPLETED","sponsor":"Natividad Medical Center","startDate":"2006-08","conditions":"Methicillin Resistant Staphylococcus Aureus Skin Infections","enrollment":31},{"nctId":"NCT00495313","phase":"PHASE4","title":"Safety and Efficacy Study to Compare Two Rosacea Treatment Regimens","status":"COMPLETED","sponsor":"CollaGenex Pharmaceuticals","startDate":"2007-03","conditions":"Rosacea","enrollment":91}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"topical tetracycline","genericName":"topical tetracycline","companyName":"Johns Hopkins University","companyId":"johns-hopkins-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Topical tetracycline is used to treat conditions such as acne vulgaris, diabetic foot ulcers, and trichiasis, as well as to prevent surgical site infections in head and neck cancer patients. It works by inhibiting the bacterial 70S ribosome, a mechanism that is characteristic of its classification as a small molecule inhibitor.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}